Cargando…

Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells

Wogonin, a flavonoid derived from Scutellaria baicalensis Georgi, has been demonstrated to be highly effective in treating hematologic malignancies. In this study, we investigated the anticancer effects of wogonin on K562 cells, K562 imatinib-resistant cells, and primary patient-derived CML cells. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hao, Hui, Hui, Wang, Qian, Li, Hui, Zhao, Kai, Zhou, Yuxin, Zhu, Yu, Wang, Xiaotang, You, Qidong, Guo, Qinglong, Lu, Na
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226676/ https://www.ncbi.nlm.nih.gov/pubmed/25149543 http://dx.doi.org/10.18632/oncotarget.2340

Ejemplares similares

Correction: Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells
por: Yang, Hao, et al.
Publicado: (2020)

BM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversal by Wogonin
por: Xu, Xuefen, et al.
Publicado: (2016)

Wogonin reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12-CXCR4/7 axis in bone marrow microenvironment
por: Cao, Hanbo, et al.
Publicado: (2020)

Effect of magnetic nanoparticles of Fe(3)O(4) and wogonin on the reversal of multidrug resistance in K562/A02 cell line
por: Cheng, Jian, et al.
Publicado: (2012)

Effects of THAP11 on Erythroid Differentiation and Megakaryocytic Differentiation of K562 Cells
por: Kong, Xiang-Zhen, et al.
Publicado: (2014)

Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation
por: Lee, Yueh-Lun, et al.
Publicado: (2013)

Induction of Erythroid Differentiation by 5‐Fluorouracil in K562 Leukemia Cells
por: Yang, Ya‐Wun, et al.
Publicado: (1995)

Wogonin inhibits the proliferation of myelodysplastic syndrome cells through the induction of cell cycle arrest and apoptosis
por: LU, HUIXIA, et al.
Publicado: (2015)

Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation
por: Lee, Yueh-Lun, et al.
Publicado: (2017)

Apoptotic Mechanism of Human Leukemia K562/A02 Cells Induced by Magnetic Ferroferric Oxide Nanoparticles Loaded with Wogonin
por: Peng, Miao-Xin, et al.
Publicado: (2016)

Inhibition of YAP suppresses CML cell proliferation and enhances efficacy of imatinib in vitro and in vivo
por: Li, Hui, et al.
Publicado: (2016)

Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition
por: Li, Lv, et al.
Publicado: (2012)

Anti-Proliferative Effect of Wogonin on Ovary Cancer Cells Involves Activation of Apoptosis and Cell Cycle Arrest
por: Zhao, Qingyang, et al.
Publicado: (2019)

MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells
por: Yuan, Jin-Yun, et al.
Publicado: (2009)

Proteome Changes Induced by Imatinib and Novel Imatinib Derivatives in K562 Human Chronic Myeloid Leukemia Cells
por: Arvaniti, Katerina, et al.
Publicado: (2014)

Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells
por: Wang, Lei, et al.
Publicado: (2012)

Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells
por: Prado-Carrillo, Omar, et al.
Publicado: (2022)

Effects of miR-210-3p on the erythroid differentiation of K562 cells under hypoxia
por: Hu, Caiyan, et al.
Publicado: (2021)

Unravelling pathways downstream Sox6 induction in K562 erythroid cells by proteomic analysis
por: Barbarani, Gloria, et al.
Publicado: (2017)

Liproxstatin-1 induces cell cycle arrest, apoptosis, and caspase-3/GSDME-dependent secondary pyroptosis in K562 cells
por: Dong, Hai-Qun, et al.
Publicado: (2022)

Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients
por: Brusic, Ana, et al.
Publicado: (2012)

Combination of panobinostat with ponatinib synergistically overcomes imatinib‐resistant CML cells
por: Matsuda, Yasufumi, et al.
Publicado: (2016)

Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity
por: Long, Mark D., et al.
Publicado: (2015)

Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence
por: Drullion, C, et al.
Publicado: (2012)

New Imatinib Derivatives with Antiproliferative Activity against A549 and K562 Cancer Cells
por: Oliveira, Andressa, et al.
Publicado: (2022)

Wogonin Suppresses Melanoma Cell B16-F10 Invasion and Migration by Inhibiting Ras-Medicated Pathways
por: Zhao, Kai, et al.
Publicado: (2014)

HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells
por: Chen, Shu-Huey, et al.
Publicado: (2019)

SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation
por: Giallongo, Cesarina, et al.
Publicado: (2013)

Inhibitory Effect of Mesenchymal Stem Cell Co-Culture on Erythroid Differentiation of K562 Cells Compared to The Control Group
por: Saleh, Mahshid, et al.
Publicado: (2017)

6,7-Dimethoxycoumarin Influences the Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells through Regulating FOXO3/p27 Signal Pathway
por: Zheng, Li, et al.
Publicado: (2022)

Inhibition of c-MYC-miRNA 19 Pathway Sensitized CML K562 Cells to Etoposide via NHE1 Upregulation
por: Cao, Shannan, et al.
Publicado: (2022)

Semi-random mutagenesis profile of BCR-ABL during imatinib resistance acquirement in K562 cells
por: Dong, Yan, et al.
Publicado: (2017)

The Effects of Antisense miRNA-20a Alone or in Combination with Imatinib on K562 Cell Proliferation
por: Zhou, Ying, et al.
Publicado: (2017)

Alternative splicing of apoptosis-related genes in imatinib-treated K562 cells identified by exon array analysis
por: LIU, JING, et al.
Publicado: (2011)

Carbon Monoxide Induced Erythroid Differentiation of K562 Cells Mimics the Central Macrophage Milieu in Erythroblastic Islands
por: Toobiak, Shlomi, et al.
Publicado: (2012)

Inhibition of abl Oncogene Tyrosine Kinase Induces Erythroid Differentiation of Human Myelogenous Leukemia K562 Cells
por: Honma, Yoshio, et al.
Publicado: (1990)

Regulation of erythroid differentiation in K562 cells by the EPAS1-IRS2 axis under hypoxic conditions
por: Gao, Zhan, et al.
Publicado: (2023)

Induction of the Erythroid Differentiation of K562 Cells Is Coupled with Changes in the Inter-Chromosomal Contacts of rDNA Clusters
por: Tchurikov, Nickolai A., et al.
Publicado: (2023)

Reply: The long-term response to imatinib treatment of CML
por: Michor, F
Publicado: (2007)

Spred2 Modulates the Erythroid Differentiation Induced by Imatinib in Chronic Myeloid Leukemia Cells
por: Yang, Yuefeng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_euhrdsd22c8dg5geg72ap1fpdn